Abstract
During the conducted research, it is established that aluminium chloride intoxication leads to the considerable changes of composition of red blood, development of a hypercalcemia and change of a bone structure of animals. A number of significant morphofunctional changes in the hippocampus of the examined animals are also noted. The use of the tissue preparation "Nicavet-1000" leads to the normalization of both hematocrit and other parameters of red blood, as well as to the intensification of erythropoiesis. Use of the preparation "Nicavet-1000", judging from the results of research, prevents pathological changes in a bone tissue, caused by aluminium chloride. "Nicavet-1000" leads to the expressed normalization of both the morphological, and micromorphometric parameters characterizing a hippocampus of rats.
References
Exley C. Hippocampus. Amsterdam: Elsevier Science; 2001.
O'Neil MJ, editor. The Merck Index: An Encyclopedia of Chemicals, Drugs, and Biologicals. 13th ed. New York: Merck and Co.; 2001.
Aremu DA, Meshitsuka S, Nose T. A Risk of Alzheimer's Disease and Aluminum in Drinking Water. Psychogeriatrics 2002; 2(4): 263-8. https://doi.org/10.1111/j.1479-8301.2002.tb00039.x
Whitehead MW, Farrar G, Christie GL, et al. Mechanisms of aluminum absorption in rats. Am J Clin Nutr 1997; 65(5): 1446-52.
Priest ND, Talbot RJ, Austin JG, et al. The bioavailability of 26 Al-labelled aluminium citrate and aluminium hydroxide in volunteers. BioMetals 1996; 9(3): 221-8. https://doi.org/10.1007/BF00817919
Gorsky JE, Dietz AA, Spencer H, Osis D. Metabolic balance of aluminum studied in six men. Clin Chem 1979; 25(10): 1739-43.
Sigel H, Sigel A, editor. Concepts for Metal Ion Toxicity. New York: Marcel Dekker; 1986.
Chmielnicka J, Nasiadek M, Lewandowska-Zyndul E. The effect of aluminum chloride on some steps of heme biosynthesis in rats after oral exposure. Biol Trace Elem Res 1994; 40(2): 127-36. https://doi.org/10.1007/BF02950786
Osi?ska E, Kanoniuk D, Kusiak A. Aluminum hemotoxicity mechanisms. Ann Univ Mariae Curie Sklodowska Med 2004; 59(1): 411-6.
Mailloux R J, Lemire J, Appanna VD. Hepatic response to aluminum toxicity: dyslipidemia and liver diseases. Exp Cell Res 2011; 317(16): 2231-8. https://doi.org/10.1016/j.yexcr.2011.07.009
Lemire J, Appanna VD. Aluminum toxicity and astrocyte dysfunction: a metabolic link to neurological disorders. Biochem 2011; 105(11): 1513-7. https://doi.org/10.1016/j.jinorgbio.2011.07.001
Chagnac A, Ben-Bassat M, Weinstein T, Levi J. Effect of Long-Term Aluminum Administration on the Renal Structure of the Rat. Nephron 1987; 47(1): 66-9. https://doi.org/10.1159/000184459
Yuan CY, Lee YJ, Hsu GS. Aluminum overload increases oxidative stress in four functional brain areas of neonatal rats. J Biomed Sci 2012; 19(1): 51. https://doi.org/10.1186/1423-0127-19-51
Markesbery WR. Oxidative stress hypothesis in Alzheimer's disease. Free Radic Biol Med 1997; 23(1): 134-47. https://doi.org/10.1016/S0891-5849(96)00629-6
González-Domínguez R, García-Barrera T, Gómez-Ariza JL. Homeostasis of metals in the progression of Alzheimer’s disease. BioMetals 2014; 27(3): 539-49. https://doi.org/10.1007/s10534-014-9728-5
Saber A, Mohammed F, Al Zubaidy I, et al. Does Aluminum Really Enhance Alzheimer Disease? Medical Impact of Aluminum on Human Health. European Journal of Scientific Research 2015; 136(1): 10-21.
Zhang QL, Jia L, Jiao X, et al. APP/PS1 transgenic mice treated with aluminum: an update of Alzheimer's disease model. Int J Immunopathol Pharmacol 2012; 25(1): 49-58. https://doi.org/10.1177/039463201202500107
Tomek SE, LaCrosse AL, Nemirovsky NE, et al. NMDA Receptor Modulators in the Treatment of Drug Addiction. Pharmaceuticals 2013; 6(2): 251-68. https://doi.org/10.3390/ph6020251
Berridge MJ. Dysregulation of neural calcium signaling in Alzheimer disease, bipolar disorder and schizophrenia. Prion 2013; (7)1: 2-13. https://doi.org/10.4161/pri.21767
Platt B, Fiddler G, Riedel G, et al. Aluminium toxicity in the rat brain: histochemical and immunocytochemical evidence. Brain Res Bull 2001; 55(2): 257-67. https://doi.org/10.1016/S0361-9230(01)00511-1
Alishah S, Ullah F, Yoon GH. Nanoscale-alumina induces oxidative stress and accelerates amyloid beta (A?) production in ICR female mice. Nanoscale 2015; 7(37): 15225-37. https://doi.org/10.1039/C5NR03598H
Kawahara M. Effects of aluminum on the nervous system and its possible link with neurodegenerative diseases. J Alzheimers Dis 2005; 8(2): 171-82. https://doi.org/10.3233/JAD-2005-8210
Sahin G, Isimer A, Temizer A, et al. The effect of aluminium loading on bones of mice. Arch Toxicol Suppl 1991; 14: 88-91. https://doi.org/10.1007/978-3-642-74936-0_18
Song M, Huo H, Cao Z, et al. Aluminum Trichloride Inhibits the Rat Osteoblasts Mineralization In vitro. Biol Trace Elem Res 2017; 175(1): 186-93. https://doi.org/10.1007/s12011-016-0761-9
Sabogal-Guáqueta AM, Muñoz-Manco JI, Ramírez-Pineda JR, et al. The flavonoid quercetin ameliorates Alzheimer's disease pathology and protects cognitive and emotional function in aged triple transgenic Alzheimer's disease model mice. Neuropharmacology 2015; 93: 134-45. https://doi.org/10.1016/j.neuropharm.2015.01.027
Maya S, Prakash T, Madhu KD, Goli D. Multifaceted effects of aluminium in neurodegenerative diseases: A review. Biomed Pharmacother 2016; 83: 746-54. https://doi.org/10.1016/j.biopha.2016.07.035
Nam SM, Kim JW, Yoo DY, et al. Reduction of adult hippocampal neurogenesis is amplified by aluminum exposure in a model of 2 diabetes. J Vet Sci 2016; 17(1): 13-20. https://doi.org/10.4142/jvs.2016.17.1.13
Cannata JB, Junor BJ, Briggs JD, Fell GS. Aluminium hydroxide intake: real risk of aluminium toxicity. Br Med J 1983; 286(6382): 1937-8. https://doi.org/10.1136/bmj.286.6382.1937-a
Graczyk A, D?ugaszek M. Biochemical processes and molecular mechanisms of aluminium toxicity (in Polish). Rocz Panstw Zakl Hig 1993; 44(1): 23-42.
Zaman K, Miszta H, D?browski Z. The effect of aluminium upon the activity of selected bone marrow enzymes in rats. Folia Haematol Int Mag Klin Morphol Blutforsch 1990; 117(3): 447-51.
Zaman K, Zaman W, D?browski Z, Miszta H. Inhibition of delta aminolevulinic acid dehydratase activity by aluminium. Comp Biochem Physiol C 1993; 104(2): 269-73. https://doi.org/10.1016/0742-8413(93)90034-I
Garay G, Grosso S, Douthat W, et al. Influence of aluminium overload on the course of post-transplant parathyroid function. Nephrol Dial Transplant 1996; 11(3): 65-8. https://doi.org/10.1093/ndt/11.supp3.65
Slanina ?, Falkeborn Y, Freeh W, Cedergren A. Aluminium concentrations in the brain and bone of rats fed citric acid, aluminium citrate or aluminium hydroxide. Food Chem Toxicol 1984; 22(5): 391-7. https://doi.org/10.1016/0278-6915(84)90369-7
Rodriguez M, Felsenfeld AJ, Llach F. The role of aluminum in the development of hypercalcemia in the rat. Kidney Int 1987; 31(3): 766-71. https://doi.org/10.1038/ki.1987.64
Oddo S, Caccamo A, Shepherd JD, et al. Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron 2003; 39(3): 409-21. https://doi.org/10.1016/S0896-6273(03)00434-3
Bezprozvanny I, Mattson MP. Neuronal calcium mishandling and the pathogenesis of Alzheimer's disease. Trends Neurosci 2008; 31(9): 454-63. https://doi.org/10.1016/j.tins.2008.06.005
Reitz C, Mayeux R. Alzheimer disease: epidemiology, diagnostic criteria, risk factors and biomarkers. Biochem Pharmacol 2014; 88(4): 640-51. https://doi.org/10.1016/j.bcp.2013.12.024
Sepulveda-Falla D, Barrera-Ocampo A, Hagel C, et al. Familial Alzheimer's disease-associated presenilin-1 alters cerebellar activity and calcium homeostasis. J Clin Invest 2014; 124(4): 1552-67. https://doi.org/10.1172/JCI66407
Magi S, Castaldo P, Macrì ML, et al. Intracellular Calcium Dysregulation: Implications for Alzheimer's Disease. Biomed Res Int 2016; 2016: e6701324.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright (c) 2017 David A. Areshidze, Lyudmila D. Timchenko, Igor V. Rzhepakovsky, Maria A. Kozlova, Iaroslavna A. Kusnetsova , Ivan A. Syomin